Levosimendan for sepsis-induced myocardial dysfunction friend or foe (2025) Xinxin Du

Description

This review summarizes the therapeutic mechanisms of levosimendan, a novel inotrope, in treating Sepsis-Induced Myocardial Dysfunction (SIMD). It addresses the controversy surrounding its use, analyzes recent research to improve its efficacy, and explores the potential and limitations of levosimendan for SIMD treatment, providing direction for future clinical trials and applications.